Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Copper-Catalyzed Dearomative 1,2-Hydroamination.
Davis CW, Zhang Y, Li Y, Martinelli M, Zhang J, Ungarean C, Galer P, Liu P, Sarlah D. Davis CW, et al. Angew Chem Int Ed Engl. 2024 May 23:e202407281. doi: 10.1002/anie.202407281. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 38779787
Severe disease during both primary and secondary dengue virus infections in pediatric populations.
Aggarwal C, Ahmed H, Sharma P, Reddy ES, Nayak K, Singla M, Maheshwari D, Chawla YM, Panda H, Rai RC, Gunisetty S, Priyamvada L, Bhaumik SK, Ahamed SF, Vivek R, Bhatnagar P, Singh P, Kaur M, Dixit K, Kumar S, Gottimukkala K, Saini K, Bajpai P, Sreekanth GP, Mammen S, Rajan A, Verghese VP, Abraham AM, Shah P, Alagarasu K, Yu T, Davis CW, Wrammert J, Ansari A, Antia R, Kabra SK, Medigeshi GR, Ahmed R, Lodha R, Shet A, Chandele A, Murali-Krishna K. Aggarwal C, et al. Among authors: davis cw. Nat Med. 2024 Mar;30(3):670-674. doi: 10.1038/s41591-024-02798-x. Epub 2024 Feb 6. Nat Med. 2024. PMID: 38321219
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression.
Friedes C, Yegya-Raman N, Zhang S, Iocolano M, Cohen RB, Aggarwal C, Thompson JC, Marmarelis ME, Levin WP, Cengel KA, Ciunci CA, Singh AP, D'Avella C, Davis CW, Langer CJ, Feigenberg SJ. Friedes C, et al. Among authors: davis cw. Clin Lung Cancer. 2024 Jan;25(1):50-60.e6. doi: 10.1016/j.cllc.2023.09.002. Epub 2023 Sep 17. Clin Lung Cancer. 2024. PMID: 37813713
Light chain of a public SARS-CoV-2 class-3 antibody modulates neutralization against Omicron.
Patel A, Kumar S, Lai L, Keen M, Valanparambil R, Chakravarthy C, Laughlin Z, Frank F, Cheedarla N, Verkerke HP, Neish AS, Roback JD, Davis CW, Wrammert J, Sharma A, Ahmed R, Suthar MS, Murali-Krishna K, Chandele A, Ortlund E. Patel A, et al. Among authors: davis cw. Cell Rep. 2023 Sep 26;42(9):113150. doi: 10.1016/j.celrep.2023.113150. Epub 2023 Sep 13. Cell Rep. 2023. PMID: 37708028 Free PMC article.
New global indicator for workers' health: mortality rate from diseases attributable to selected occupational risk factors.
Pega F, Al-Emam R, Cao B, Davis CW, Edwards SJ, Gagliardi D, Fassa AG, Hassan MN, Hosseinpoor AR, Iavicoli S, Jandaghi J, Jarosinska DI, Kgalamono SM, Rad MK, Khodabakshi M, Li X, Marinaccio A, Mbayo G, Rowshani Z, Sanabria NM, Sidwell-Wilson K, Solar OH, Streicher KN, Sun X, Asl RT, Yadegari M, Zhang S, Zungu M, Momen NC. Pega F, et al. Among authors: davis cw. Bull World Health Organ. 2023 Jun 1;101(6):418-430Q. doi: 10.2471/BLT.23.289703. Epub 2023 May 1. Bull World Health Organ. 2023. PMID: 37265682 Free PMC article.
Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response.
Patel A, Kumar S, Lai L, Chakravarthy C, Valanparambil R, Reddy ES, Gottimukkala K, Bajpai P, Raju DR, Edara VV, Davis-Gardner ME, Linderman S, Dixit K, Sharma P, Mantus G, Cheedarla N, Verkerke HP, Frank F, Neish AS, Roback JD, Davis CW, Wrammert J, Ahmed R, Suthar MS, Sharma A, Murali-Krishna K, Chandele A, Ortlund EA. Patel A, et al. Among authors: davis cw. Structure. 2023 Jul 6;31(7):801-811.e5. doi: 10.1016/j.str.2023.04.010. Epub 2023 May 11. Structure. 2023. PMID: 37167972 Free PMC article.
193 results